Your browser doesn't support javascript.
loading
Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits.
Rossetti, Giacomo G; Ossorio, Marianna A; Rempel, Stephan; Kratzel, Annika; Dionellis, Vasilis S; Barriot, Samia; Tropia, Laurence; Gorgulla, Christoph; Arthanari, Haribabu; Thiel, Volker; Mohr, Peter; Gamboni, Remo; Halazonetis, Thanos D.
Afiliação
  • Rossetti GG; Department of Molecular Biology, University of Geneva, 1205, Geneva, Switzerland.
  • Ossorio MA; FoRx Therapeutics AG, 4056, Basel, Switzerland.
  • Rempel S; Department of Molecular Biology, University of Geneva, 1205, Geneva, Switzerland.
  • Kratzel A; FoRx Therapeutics AG, 4056, Basel, Switzerland.
  • Dionellis VS; Institute of Virology and Immunology, University of Bern, 3012, Bern, Switzerland.
  • Barriot S; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012, Bern, Switzerland.
  • Tropia L; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
  • Gorgulla C; Department of Molecular Biology, University of Geneva, 1205, Geneva, Switzerland.
  • Arthanari H; Department of Molecular Biology, University of Geneva, 1205, Geneva, Switzerland.
  • Thiel V; Department of Molecular Biology, University of Geneva, 1205, Geneva, Switzerland.
  • Mohr P; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Harvard University, Boston, MA, 02115, USA.
  • Gamboni R; Department of Physics, Faculty of Arts and Sciences, Harvard University, Cambridge, MA, 02138, USA.
  • Halazonetis TD; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.
Sci Rep ; 12(1): 2505, 2022 02 15.
Article em En | MEDLINE | ID: mdl-35169179

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Proteases 3C de Coronavírus / SARS-CoV-2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Proteases 3C de Coronavírus / SARS-CoV-2 Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça